Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Berkowitz, H. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Berkowitz, H. L.
Related Collections
* Depression
* Stroke
* Other Somatic Therapy
Psychosomatics 46:93, February 2005
© 2005 The Academy of Psychosomatic Medicine


Letter

Modafinil in Poststroke Depression

Howard L. Berkowitz, M.D., Maimonides Medical Center, Brooklyn, N.Y.

To the Editor: Steven G. Sugden, M.D., and James A. Bourgeois, O.D., M.D.,1 reported on the apparently successful treatment of "an elderly woman" (age unspecified) who supposedly developed depression subsequent to a ruptured berry aneurysm, resulting in a right frontal hematoma and frontal lobe hydrocephalus later treated with a ventriculostomy.

It should be noted that the criteria for major depression were never established and that the patient, in fact, was described as "apathetic and lethargic." The patient, who had been taking lithium before the hematoma, continued to take lithium subsequent to the bleed, but no lithium level was provided at any point in the patient’s course. She was described as initially "unable to complete any components of the Folstein Mini-Mental Status Examination (MMSE)." The trial of modafinil was started the same day that lithium was discontinued. After 3 days of modafinil and no lithium, the patient was described as "more alert and spontaneously engaged in conversation." After 10 days of modafinil and no lithium, her MMSE score was 21.

This case report, as presented, leaves the reader confused as to whether the symptoms represented true depression or stroke-induced apathy and whether the presence of lithium in an elderly patient who had suffered brain damage could be responsible for some of the reported symptoms.

REFERENCES

  1. Sugden SG, Bourgeois JA: Modafinil monotherapy in poststroke depression. Psychosomatics 2004; 45:80–81[Free Full Text]




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Berkowitz, H. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Berkowitz, H. L.
Related Collections
* Depression
* Stroke
* Other Somatic Therapy


Get information about faster international access.

Privacy Policy

Copyright © 2005 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org